Prevalence and characteristics of mental and physical disorders among female prisoners: a mixed-methods systematic review

Friestad, Christine; Haukvik, Unn K.; Johnsen, Berit; Vatnar, Solveig Karin Bø

doi:10.1108/ijph-12-2022-0080

Cited by 2 publications

(3 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because both of MADOC’s female-population prisons implemented buprenorphine in April 2019, the entire female population gained access from the start, compared with only 2 out of the 11 male-population MADOC prisons. Additionally, the female sample in MADOC may have had a higher prevalence of OUD and therein a greater proportion who stood to gain from access to buprenorphine, which was evidenced by their higher postrelease overdose rates (in this study and others) and would mirror prevalence estimates in national carceral samples . Furthermore, the female MADOC sample includes some county jail populations, which typically have a higher prevalence of substance use disorders than prison populations…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

“…Additionally, the female sample in MADOC may have had a higher prevalence of OUD and therein a greater proportion who stood to gain from access to buprenorphine, which was evidenced by their higher postrelease overdose rates (in this study and others 50,51 ) and would mirror prevalence estimates in national carceral samples. [52][53][54][55] Furthermore, the female MADOC sample includes some county jail populations, which typically have a higher prevalence of substance use disorders than prison populations. 53 Although our study may have been underpowered for these rarer outcomes, we nonetheless found a small decrease in postrelease mortality in the male cohort (statistically significant) and a small decrease in postrelease overdose in the female cohort (although not statistically significant).…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes

Bovell-Ammon,

Yan,

Dunn

et al. 2024

JAMA Netw Open

View full text Add to dashboard Cite

ImportanceAgonist medications for opioid use disorder (MOUD), buprenorphine and methadone, in carceral settings might reduce the risk of postrelease opioid overdose but are uncommonly offered. In April 2019, the Massachusetts Department of Correction (MADOC), the state prison system, provided buprenorphine for incarcerated individuals in addition to previously offered injectable naltrexone.ObjectiveTo evaluate postrelease outcomes after buprenorphine implementation.Design, Setting, and ParticipantsThis cohort study with interrupted time-series analysis used linked data across multiple statewide data sets in the Massachusetts Public Health Data Warehouse stratified by sex due to differences in carceral systems. Eligible participants were individuals sentenced and released from a MADOC facility to the community. The study period for the male sample was January 2014 to November 2020; for the female sample, January 2015 to October 2019. Data were analyzed between February 2022 and January 2024.ExposureApril 2019 implementation of buprenorphine during incarceration.Main Outcomes and MeasuresReceipt of MOUD within 4 weeks after release, opioid overdose, and all-cause mortality within 8 weeks after release, each measured as a percentage of monthly releases who experienced the outcome. Segmented linear regression analyzed changes in outcome rates after implementation.ResultsA total of 15 225 individuals were included. In the male sample there were 14 582 releases among 12 688 individuals (mean [SD] age, 35.0 [10.8] years; 133 Asian and Pacific Islander [0.9%], 4079 Black [28.0%], 4208 Hispanic [28.9%], 6117 White [41.9%]), a rate of 175.7 releases per month; the female sample included 3269 releases among 2537 individuals (mean [SD] age, 34.9 [9.8] years; 328 Black [10.0%], 225 Hispanic [6.9%], 2545 White [77.9%]), a rate of 56.4 releases per month. Among male participants at 20 months postimplementation, the monthly rate of postrelease buprenorphine receipt was higher than would have been expected under baseline trends (21.2% vs 10.6% of monthly releases; 18.6 additional releases per month). Naltrexone receipt was lower than expected (1.0% vs 6.0%; 8.8 fewer releases per month). Monthly rates of methadone receipt (1.4%) and opioid overdose (1.8%) were not significantly different than expected. All-cause mortality was lower than expected (1.9% vs 2.8%; 1.5 fewer deaths per month). Among female participants at 7 months postimplementation, buprenorphine receipt was higher than expected (31.6% vs 9.5%; 12.4 additional releases per month). Naltrexone receipt was lower than expected (3.4% vs 7.2%) but not statistically significantly different. Monthly rates of methadone receipt (1.1%), opioid overdose (4.8%), and all-cause mortality (1.6%) were not significantly different than expected.Conclusions and RelevanceIn this cohort study of state prison releases, postrelease buprenorphine receipt increased and naltrexone receipt decreased after buprenorphine became available during incarceration.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes

Bovell-Ammon,

Yan,

Dunn

et al. 2024

JAMA Netw Open

View full text Add to dashboard Cite

show abstract

Women in acute forensic psychiatric care: comparison of clinical, sociodemographic, and detention-related characteristics in pretrial detention, sentence execution, and court-ordered treatment

D’Orta,

Weber,

Herrmann

et al. 2024

BMC Psychiatry

View full text Add to dashboard Cite

Compared to men inmates, women display decreased prevalence of severe mental disorder but increased occurrence of substance use disorders (SUD) and higher rates of previous contacts with mental health services. The group of women in detention is highly heterogeneous according to the status of incarceration (pre-trial detention (PTD), sentence execution (SE) and court ordered treatments (COT)). Studies focusing on the comparison of sociodemographic patterns, detention-related and clinical variables between these groups are still lacking. We explored these parameters in 136 women admitted for acute psychiatric care in the sole Geneva forensic unit during a nine year period (2014–2023). Sociodemographic and detention-related data included age, nationality, marital status, presence of children, education attainment, most frequently speaking language, social support, employment before conviction and type of offenses. Clinical variables included the main ICD-10 diagnosis, presence of concomitant SUD, type of personality disorders, presence of suicidal thoughts and attempts at admission, as well as number and mean duration of stays. PTD and SE women had at least 9 years of formal education in 38.9% and 30.3% of cases. Most women in PTD (77.7%), SE (56.6%) and COT (56.2%) groups were Swiss or European citizens. The level of French knowledge was excellent in most of the cases. 43.8% of COT women had at least one child and this percentage is even higher for PTD and SE cases. The employment rate before conviction was also quite high, mainly for PTD and SE (61.1% and 60.6%) and, in a lesser degree, for COT (43.8%) women. Significant social support was present in the vast majority of women without any significant group difference. The distribution of type of offenses did not differ between the three types of detention with a predominance of physical violence, and drug trafficking. The number of stays during the period of reference was significantly higher in COT compared to both SE and PTD women. History of previous inpatient care was also significantly more frequent in COT that SE and PTD women. Adjustment and affective disorders were more often found in SE and PTD cases, these diagnoses were absent in the COT group. In contrast, a main diagnosis of psychotic disorders was found in 62.5% of COT cases compared to only 21.2% in SE and 24.1% in PTD cases. The number of stays, history of inpatient care and diagnosis of psychosis were independent predictors of COT status. In conclusion, the present data reveal the good social integration and emotional support of women needing acute psychiatric care in prison independently of the type of detention. Clinically, women in PTD and SE display more often emotional distress whereas those in COT suffer from acute psychotic symptoms with previous history of psychiatric care and multiple inpatient stays.

show abstract

Prevalence and characteristics of mental and physical disorders among female prisoners: a mixed-methods systematic review

Cited by 2 publications

References 57 publications

Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes

Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes

Women in acute forensic psychiatric care: comparison of clinical, sociodemographic, and detention-related characteristics in pretrial detention, sentence execution, and court-ordered treatment

Contact Info

Product

Resources

About